News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
England’s first Integrated Pathology Unit focusing on clinical trial research will use novel technology to diagnose cancer faster and more affordably
England’s first centre of its kind is set to make significant improvements in cancer diagnosis and treatment – by combining pioneering digital imaging with artificial intelligence.
Cell ‘nanobot’ breakthrough shines light on cause of aggressive cancers
Scientists have uncovered the inner workings of one of the most important and intricate ‘nanobots’ operating within our cells – using cutting-edge microscopy for visualising molecules almost at an atomic level. Their new study published in Nature has unveiled the critical step that switches on the spliceosome – a piece of cellular machinery that enables cells to build complex proteins.
ICR’s Chief Executive elected as Foreign Member of the Royal Society
Professor Kristian Helin, a world-leading cancer researcher and Chief Executive of The Institute of Cancer Research, London, has been elected as a Foreign Member of the Royal Society in recognition of his outstanding contribution to cancer research.
ICR-discovered drug to enter phase II clinical trial in ovarian cancer thanks to new research collaboration
An innovative cancer drug discovered by scientists at The Institute of Cancer Research, London, is set to enter a new clinical trial.
AI could help doctors diagnose lung cancer
Artificial intelligence (AI) could help doctors diagnose lung cancer earlier, according to a study led by researchers from The Royal Marsden NHS Foundation Trust in collaboration with The Institute of Cancer Research, London, and Imperial College London.
Scientists create potent ‘degrader’ of cancer-driving protein
Scientists at The Institute of Cancer Research, London, have created a compound that destroys a protein involved in driving cancers, including B-cell lymphoma.
ICR saddened by death of Gerry Potter
Former colleagues at The Institute of Cancer Research, London, have reacted with great sadness to news of the untimely death of Gerry Potter, at the age of 63.
Art and science collide in a creative collaboration between The London Cancer Hub and the Sutton community
An inspirational film featuring local dance groups, members of the Sutton community and scientists from The Institute of Cancer Research, London, premiered this month as part of a festival celebrating arts, science and culture in Sutton.
Immuno-oncology collaboration to develop innovative new type of cancer drug
Scientists at The Institute of Cancer Research, London, are teaming up with small molecule neoantigen immuno-oncology company NeoPhore to develop new potential cancer drugs.
New study reveals key priorities to guide US President Biden’s Cancer Moonshot
Researchers have revealed a set of recommendations to help reach the US Cancer Moonshot’s target of cutting cancer deaths by half in the next 25 years.
.jpg?sfvrsn=b8be1e0b_2 "breast cancer cell 547x410 (1)")
ICR hails ‘momentous’ recommendation of olaparib for breast and prostate cancer
The Institute of Cancer Research, London, has hailed the ‘life-changing’ decision by NICE to recommend that the targeted drug olaparib can be used for NHS patients with both early-stage breast cancer and prostate cancer.
-547x410.jpg?sfvrsn=5e98f2c_2 "Clinical trials pharmacy (Jan Chlebik for the ICR, 2014) 547x410")
Innovative first in class HSF1 pathway cancer drug shows strong results in new study
A new, oral ‘first in class’ experimental cancer drug has shown potent activity against cancer cells and caused shrinkage of hard-to-treat human ovarian tumours grown in mice, a new study shows.
